Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-03-09
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Cancer Insight, LLC
- Target Recruit Count
- 45
- Registration Number
- NCT04787991
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Stanford University, Stanford, California, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
Immunotherapy Vaccine and Herceptin in Breast Cancer
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-01-09
- Last Posted Date
- 2017-01-09
- Lead Sponsor
- Cancer Insight, LLC
- Target Recruit Count
- 30
- Registration Number
- NCT03014076
Phase IIB TL + YCWP + DC in Melanoma
- First Posted Date
- 2014-11-26
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Elios Therapeutics, LLC
- Target Recruit Count
- 187
- Registration Number
- NCT02301611
- Locations
- 🇺🇸
John Wayne Cancer Institute, Santa Monica, California, United States
🇺🇸Northside Hospital Cancer Institute, Atlanta, Georgia, United States
🇺🇸Northwestern Memorial Hospital, Chicago, Illinois, United States
Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-11-21
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- Cancer Insight, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT02297698
- Locations
- 🇺🇸
Florida Cancer Research Institute, Plantation, Florida, United States
🇺🇸Loyola University Medical Center, Maywood, Illinois, United States
🇺🇸Memorial Hospital of South Bend, South Bend, Indiana, United States
© Copyright 2024. All Rights Reserved by MedPath